Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A mutant based on autophagy key protein atg7 and its application

A key protein and mutant technology, applied in the field of biotechnology and anti-aging treatment, to achieve the effects of controllable purity, improved cell proliferation status, and simple preparation method

Active Publication Date: 2021-11-02
中国医科大学
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Current approaches to slowing aging are mostly based on molecules that affect metabolic pathways rather than functional proteins that play active regulatory roles

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A mutant based on autophagy key protein atg7 and its application
  • A mutant based on autophagy key protein atg7 and its application
  • A mutant based on autophagy key protein atg7 and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Example 1 is based on the preparation of a mutant of the key autophagy protein ATG7.

[0024] A mutant based on the key autophagy protein ATG7, the amino acid sequence of which is SEQ ID No1, wherein the 411st and 413th lysines are mutated to glutamine, and the 513th, 514th and 516th amino acids are mutated to arginine.

[0025] The preparation method of the mutant based on the key autophagy protein ATG7 is as follows: using a eukaryotic expression system, overexpressing the plasmid of the mutant ATG7 with a flag tag in HEK293T cells, collecting the cells after 48 hours of expression, extracting the protein, Add flag-beads to the protein extract, mix overnight at 4°C, collect flag-beads at 4°C, use flag-peptide to compete for the elution of the ATG7 protein mutant, and the eluent is the purified ATG7 protein mutant.

Embodiment 2

[0026] Example 2 is based on the pharmacological study of mutants of the key autophagy protein ATG7.

[0027] 1. Establishment of senescent cell model and experimental grouping.

[0028] Firstly, primary mouse embryonic fibroblasts (MEFs) were cultured. Take 13.5-day-old mouse embryos, separate the trunk into 1×PBS; discard the PBS, add 0.125% trypsin, and digest in a 37°C incubator for 15-20min. Planting medium (DMEM+15% serum) was used to stop digestion, centrifuged at room temperature, and the precipitate was resuspended and planted in a 6cm2 cell culture dish. After genotype identification, ATG7- / - MEFs were used to infect lentivirus negative control and flag-ATG7 mutants, respectively.

[0029] 2. Detection of cell nucleus morphology.

[0030] MEF cells stably overexpressing the negative control and flag-ATG7 mutants were subcultured in vitro, and poly-lysine was coated with cell slides in a 12-well plate at room temperature for 2 hours. The first-generation MEFs pass...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of biotechnology and anti-aging treatment, and relates to a mutant based on the key autophagy protein ATG7 and its application in anti-aging treatment, in particular to simulating protein modification state through amino acid site mutation and its role in anti-aging application in therapy. A mutant based on the key autophagy protein ATG7, its amino acid sequence is SEQ ID No1, wherein the 411th and 413th lysines are mutated to glutamine, and the 513th, 514th and 516th amino acids are mutated to arginine, so The application of the above-mentioned mutant based on the key autophagy protein ATG7 in the preparation of drugs targeted at delaying aging or preventing and treating aging-related diseases. The mutants based on the key autophagy protein ATG7 provided by the present invention have been verified by experiments, and can improve the function of the nucleus, improve the state of cell proliferation, and improve the state of cell metabolism to exert the pharmacological effect of delaying aging.

Description

technical field [0001] The invention belongs to the field of biotechnology and anti-aging treatment, and relates to a mutant based on the key autophagy protein ATG7 and its application in anti-aging treatment, in particular to simulating protein modification state through amino acid site mutation and its role in anti-aging application in therapy. Background technique [0002] Aging, as an inevitable natural life process, is a ubiquitous phenomenon in nature and is accompanied by the gradual decline of tissue and organ functions. With the process of human aging, the risk of senile diseases such as cardiovascular disease, neurodegenerative disease, cancer, diabetes, etc. also increases. Therefore, delaying aging is of great significance for the prevention and treatment of aging-related diseases. With the continuous exploration of aging mechanisms, aging is closely related to genetic and epigenetic changes. Therefore, obtaining suitable protein modification targets has becom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/47A61K38/17A61P39/06
CPCA61K38/00A61P39/06C07K14/47
Inventor 王卓曹流郭文东宋晓宇周婷婷
Owner 中国医科大学
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com